These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6802993)

  • 1. Efficacy, tolerance, and safety of colestipol HCL as a hypocholesterolemic agent in hyperlipidemic patients with studies of its effect on gastrointestinal absorption.
    Faruqui AM; Thurmond MS; Wenger J; Wenger NK
    J Pak Med Assoc; 1981 Nov; 31(11):241-5. PubMed ID: 6802993
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
    Mordasini R; Twelsick F; Oster P; Schellenberg B; Raetzer H; Heuck CC; Schlierf G
    Monatsschr Kinderheilkd (1902); 1978 Jul; 126(7):436-40. PubMed ID: 672910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
    Day CE
    Artery; 1990; 17(5):281-8. PubMed ID: 2396902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid sequestrants and hyperlipidaemia.
    Lancet; 1988 Jan; 1(8579):220-1. PubMed ID: 2893044
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypertriglyceridemia: a relative contraindication to the use of bile acid-binding resins?
    Denke MA; Grundy SM
    Hepatology; 1988; 8(4):974-5. PubMed ID: 3391527
    [No Abstract]   [Full Text] [Related]  

  • 6. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anion-exchange resins in pseudomembranous colitis.
    George RH; Youngs DJ; Johnson EM; Burdon DW
    Lancet; 1978 Sep; 2(8090):624. PubMed ID: 80541
    [No Abstract]   [Full Text] [Related]  

  • 8. [Type II hyperlipoproteinemia: treatment with colestipol and procetophen].
    Sauvanet JP; Drouin P; Debry G; Mejean L; Lambert D
    Nouv Presse Med; 1978 May; 7(21):1862. PubMed ID: 673744
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of clinical studies of bile acid sequestrants for lowering plasma lipid levels.
    LaRosa J
    Cardiology; 1989; 76 Suppl 1():55-61; discussion 61-4. PubMed ID: 2653624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anion-exchange resins in antibiotic-associated colitis.
    Chang TW; Onderdonk AB; Bartlett JG
    Lancet; 1978 Jul; 2(8083):258-9. PubMed ID: 79047
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of familial hypercholesterolemia - hyperlipoproteinemia type II with anion exchange resins].
    Kusić M; Gavrilović M; Mihajlović M; Bosković B
    Vojnosanit Pregl; 1981; 38(1):23-7. PubMed ID: 7245659
    [No Abstract]   [Full Text] [Related]  

  • 12. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
    Harvengt C; Desager JP
    Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Mar; 19(3):161-80. PubMed ID: 6988203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
    Crouse JR
    Am J Med; 1987 Aug; 83(2):243-8. PubMed ID: 3618626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
    Briani G; Fellin R; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G
    G Ital Cardiol; 1975; 5(3):390-404. PubMed ID: 1149965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocholesterolemic activity of colestipol in diabetes.
    Bandisode MS; Boshell BR
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):276-84. PubMed ID: 809240
    [No Abstract]   [Full Text] [Related]  

  • 17. Results of colestipol therapy in Type II hyperlipoproteinemia.
    Lees AM; McCluskey MA; Lees RS
    Atherosclerosis; 1976; 24(1-2):129-40. PubMed ID: 182181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cholestyramine and colestipol on the absorption of phenytoin.
    Callaghan JT; Tsuru M; Holtzman JL; Hunninghake DB
    Eur J Clin Pharmacol; 1983; 24(5):675-8. PubMed ID: 6873150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood.
    Mancini M; Postiglione A; Farinaro E; Montefusco S
    Prev Med; 1983 Nov; 12(6):848-53. PubMed ID: 6676732
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia.
    Kinosian BP; Eisenberg JM
    JAMA; 1988 Apr; 259(15):2249-54. PubMed ID: 3127607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.